Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Efficacy and Safety of Intratympanic Injection of Autologous Circulating Extracellular Vesicles Plus Glucocorticoid Versus Glucocorticoid Monotherapy for Total-Type Sudden Sensorineural Hearing Loss: A Multicenter, Superiority, Randomized Controlled Clinical Trial

NCT07878559 is registered in ClinicalTrials.gov with Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University as lead sponsor.

NCT NCT07878559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07878559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Efficacy and Safety of Intratympanic Injection of Autologous Circulating Extracellular Vesicles Plus Glucocorticoid Versus Glucocorticoid Monotherapy for Total-Type Sudden Sensorineural Hearing Loss: A Multicenter, Superiority, Randomized Controlled Clinical Trial
Lead sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 15, 2026
Completion date
March 31, 2030
Enrollment
146 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sudden sensorineural hearing loss (ssnhl)